Epigenetic regulation of the Gad1 promoter has already been shown to alter Gad1 expression levels with direct consequences for the balance between excitation and inhibition in brain regions involved in certain neuropsychiatric disorders such as autism, schizophrenia, and panic disorders [28–31]. Here, GAD1 is linked to schizophrenia.